Mary J. Kuhn, Executive VP, Operations at Talecris Biotherapeutics Holdings Corp. (TLCR), sold 33,000 shares at $23.01 ($759K) on 2010-09-14, disclosed to the SEC on 2010-09-16.
Open-market sale of $759k TLCR by Executive VP, Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TLCR | SELL | 2010-11-02 | $1.1M | — | Filing → |
| TLCR | SELL | 2010-10-04 | $1.1M | — | Filing → |
| TLCR | SELL | 2010-09-03 | $1.0M | — | Filing → |